The National Myelodysplastic Syndromes (MDS) Study
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
Research Base: National Heart, Lung, and Blood Institute (NHLBI)
NCT ID: NCT02775383
NCI Protocol Number: ECOG-ACRIN-NHLBI-MDS
For more information see ClinicalTrials.gov
Myelodysplastic Syndromes (MDS)